{"id":19308,"date":"2021-04-06T21:03:47","date_gmt":"2021-04-06T19:03:47","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=19308"},"modified":"2021-04-06T21:04:51","modified_gmt":"2021-04-06T19:04:51","slug":"proqr-haalt-100-miljoen-op-met-aandelenuitgifte","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\/","title":{"rendered":"ProQR haalt 100 miljoen op met aandelenuitgifte"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">In de afgelopen tijd presenteerde Nederlands biotechbedrijf ProQR bemoedigende onderzoeksresultaten over een nieuw medicijn tegen het Usher-syndroom, een aandoening waarbij pati\u00ebnten geleidelijk blind en doof worden. ProQR maakt daarnaast bekend dat het dit jaar twee vervolgstudies gaat doen.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">De berichten vormden volgens verschillende media de opmaat naar de uitgifte van bijna 14 miljoen nieuwe aandelen, waarmee ProQR ruim 100 miljoen dollar ophaalt.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bronnen:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><a href=\"https:\/\/fd.nl\/ondernemen\/1379089\/leids-biotechbedrijf-proqr-haalt-90-mln-op-pfd1caZewbp1\">Financieele Dagblad<\/a><\/li><li><a href=\"https:\/\/www.proqr.com\/press-releases\/proqr-announces-closing-of-underwritten-public-offering-of-ordinary-shares-with-full-exercise-of-underwriters-option-to-purchase-additional-shares\">ProQR (press release<\/a>)<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In de afgelopen tijd presenteerde Nederlands biotechbedrijf ProQR bemoedigende onderzoeksresultaten over een nieuw medicijn tegen het Usher-syndroom, een aandoening waarbij pati\u00ebnten geleidelijk blind en doof worden. ProQR maakt daarnaast bekend dat het dit jaar twee vervolgstudies gaat doen. De berichten vormden volgens verschillende media de opmaat naar de uitgifte van bijna 14 miljoen nieuwe aandelen, [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[39,43],"tags":[],"class_list":["post-19308","post","type-post","status-publish","format-standard","hentry","category-gezondheid","category-innovatieklimaat"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ProQR haalt 100 miljoen op met aandelenuitgifte - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProQR haalt 100 miljoen op met aandelenuitgifte - hollandbio\" \/>\n<meta property=\"og:description\" content=\"In de afgelopen tijd presenteerde Nederlands biotechbedrijf ProQR bemoedigende onderzoeksresultaten over een nieuw medicijn tegen het Usher-syndroom, een aandoening waarbij pati\u00ebnten geleidelijk blind en doof worden. ProQR maakt daarnaast bekend dat het dit jaar twee vervolgstudies gaat doen. De berichten vormden volgens verschillende media de opmaat naar de uitgifte van bijna 14 miljoen nieuwe aandelen, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-06T19:03:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-06T19:04:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"hollandbio\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hollandbio\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\\\/\"},\"author\":{\"name\":\"hollandbio\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/833d6a25b39946e61c6101af1fa96fbb\"},\"headline\":\"ProQR haalt 100 miljoen op met aandelenuitgifte\",\"datePublished\":\"2021-04-06T19:03:47+00:00\",\"dateModified\":\"2021-04-06T19:04:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\\\/\"},\"wordCount\":73,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"articleSection\":[\"Gezondheid\",\"Innovatieklimaat\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\\\/\",\"name\":\"ProQR haalt 100 miljoen op met aandelenuitgifte - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"datePublished\":\"2021-04-06T19:03:47+00:00\",\"dateModified\":\"2021-04-06T19:04:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProQR haalt 100 miljoen op met aandelenuitgifte\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/833d6a25b39946e61c6101af1fa96fbb\",\"name\":\"hollandbio\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ProQR haalt 100 miljoen op met aandelenuitgifte - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\/","og_locale":"en_US","og_type":"article","og_title":"ProQR haalt 100 miljoen op met aandelenuitgifte - hollandbio","og_description":"In de afgelopen tijd presenteerde Nederlands biotechbedrijf ProQR bemoedigende onderzoeksresultaten over een nieuw medicijn tegen het Usher-syndroom, een aandoening waarbij pati\u00ebnten geleidelijk blind en doof worden. ProQR maakt daarnaast bekend dat het dit jaar twee vervolgstudies gaat doen. De berichten vormden volgens verschillende media de opmaat naar de uitgifte van bijna 14 miljoen nieuwe aandelen, [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\/","og_site_name":"hollandbio","article_published_time":"2021-04-06T19:03:47+00:00","article_modified_time":"2021-04-06T19:04:51+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","type":"image\/png"}],"author":"hollandbio","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"hollandbio"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\/"},"author":{"name":"hollandbio","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/833d6a25b39946e61c6101af1fa96fbb"},"headline":"ProQR haalt 100 miljoen op met aandelenuitgifte","datePublished":"2021-04-06T19:03:47+00:00","dateModified":"2021-04-06T19:04:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\/"},"wordCount":73,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"articleSection":["Gezondheid","Innovatieklimaat"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\/","name":"ProQR haalt 100 miljoen op met aandelenuitgifte - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"datePublished":"2021-04-06T19:03:47+00:00","dateModified":"2021-04-06T19:04:51+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/proqr-haalt-100-miljoen-op-met-aandelenuitgifte\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"ProQR haalt 100 miljoen op met aandelenuitgifte"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/833d6a25b39946e61c6101af1fa96fbb","name":"hollandbio"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/19308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=19308"}],"version-history":[{"count":0,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/19308\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=19308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=19308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=19308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}